Creative Graphics Solutions India Ltd – H1 FY26 Half-Yearly Results: ₹176 Cr Revenue Run-Rate, 55% Growth, ROCE 25.7% and a Balance Sheet That Finally Grew Some Muscles
1. At a Glance – Blink and You’ll Miss the Growth
Creative Graphics Solutions India Ltd is one of those SME stocks that quietly slipped onto NSE Emerge in April 2024, did its warm-up stretches, and then suddenly started lifting serious numbers. With a market capitalisation of around ₹486 crore and a current price hovering near ₹200, the stock has had a mildly disappointing last three months on the price chart (-17.4%), but the business performance tells a very different, much louder story. Latest half-yearly consolidated sales stand at ₹176 crore, up a spicy 55.6% YoY, while half-yearly PAT clocked in at ₹12.2 crore, growing 33.4% YoY. ROE is a juicy 29.1%, ROCE a respectable 25.7%, and operating margins are holding steady around 12–13% despite aggressive expansion. Debt is present but not unhinged, promoters hold a comforting 68.1%, and the company is playing in a niche that literally prints money—packaging, labels, and pharma foils. Sounds boring? Wait till you see how fast boring can grow.
2. Introduction – From “Ink and Plates” to “Print Me Money”
If you told someone at a party that you’re researching a company that makes photopolymer plates and flexographic printing blocks, chances are they’ll politely excuse themselves to “take a call.” Creative Graphics Solutions India Ltd (CGSIL) lives in that exact zone of industrial boredom—until you open the financials.
Incorporated in 2014, CGSIL operates in pre-press solutions, manufacturing flexographic printing plates, digital flexo plates, lever press plates, and coating plates. In simple English: if it’s printed on packaging—chips packets, liquor labels, pharma strips—CGSIL is probably involved somewhere before the ink hits the substrate. Add to that aluminium-based Alu-Alu foils for pharmaceutical packaging through its subsidiary Wahren, and suddenly this is not just “ink business,” it’s regulated, sticky, high-repeat-order packaging.
The company went public via SME IPO in April 2024 and has since scaled revenue aggressively. Sales grew from ₹132 crore in FY24 to ₹251 crore in FY25, and trailing twelve-month sales are already at ₹314 crore. Profit growth has outpaced sales growth, which is rare for a manufacturing SME that’s also expanding capacity. Naturally, this raises questions. Is this a one-time post-IPO sugar rush? Or is this a boring compounding machine hiding behind packaging jargon?
Let’s put on our funny-detective hat and investigate.
3. Business Model – WTF Do They Even Do?
Think of CGSIL as the backstage crew of the packaging industry. You never see them, but without them, the show doesn’t happen.
Their core business is flexographic printing plates—used extensively in FMCG, liquor, pharma, cosmetics, and consumer goods packaging. Flexography is preferred because it’s fast, scalable, cost-efficient, and works on everything from plastic films to paper to aluminium foil. CGSIL claims to be India’s largest flexographic plate manufacturer, operating seven manufacturing units across Noida, Vasai, Mumbai, Chennai, Baddi, Hyderabad, Ahmedabad, and Pune. That geographic spread matters because packaging clients want quick turnaround times.
Then comes Wahren, the wholly owned subsidiary handling Alu-Alu pharmaceutical foils. This is not your average foil business. Pharma packaging is regulated, quality-sensitive, and high repeat. Wahren currently operates at ~50% utilisation of its 8,000 MTPA capacity, with plans to scale to 12,000 MTPA via new warehousing. Translation: operating leverage waiting patiently.
The third vertical—CG Premedia—handles mockups, premedia, and design services. This is the “sticky” part of the business. Once a brand approves designs and plates, switching suppliers becomes annoying, risky, and time-consuming.
Revenue is 96% domestic, exports around 4%, spread across Africa, Thailand, Qatar, Kuwait, and Nepal. Over 4,000 customers, including Unilever, Tata Consumer, Pernod Ricard, Zydus, Intas, and Macleods. Not bad for a company that most retail investors discovered only after the IPO.
Now ask yourself: how often do FMCG and pharma companies stop printing packaging?
Exactly.
4. Financials Overview – Numbers That Smell Like Ink and Cash
Result Type Lock
The latest reported results are Half-Yearly Results (H1 FY26). This is now locked for EPS annualisation. Annualised EPS = Latest Half-Yearly EPS × 2
